Wondfo Biotech announced on the evening of July 31 that the company recently received a confirmation letter from the World Health Organization (WHO) regarding the prequalification (PQ) of its in vitro diagnostic product, indicating that its malaria detection product has passed the WHO prequalification and has been included in the WHO list of recommended procurement for in vitro diagnostic products. This is another international recognition of the product performance and the companys quality management system, following the WHO PQ certification of its professional HIV detection product and HIV self-test product. Wondfo Biotech stated that the approval of this malaria detection product provides strong support and assurance for the company to expand into overseas markets such as Africa and Southeast Asia, and to contribute to global malaria prevention and control.